Miah Neer

Miah Neer

Auto-generated profile, based on publicly available information

Miah Neer

School of Health Administration Texas State University San Marcos, TX United States

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2022 in JMIR Mental Health
Verified
Journal Article
Open access
Clemens Scott KruseClemens Scott Kruse
Clemens Scott Kruse
Jose BetancourtJose Betancourt
Jose Betancourt
MGMatthew Gonzales
Matthew Gonzales
KDKennedy Dickerson
Kennedy Dickerson
MNMiah Neer
Miah Neer
Background: Mental health is a complex condition, highly related to emotion. The COVID-19 pandemic caused a significant spike in depression (from isolation) and anxiety (event related). Mobile Health (mHealth) and telemedicine offer solutions to augment patient care, provide education, improve symptoms of depression, and assuage fears and anxiety. Objective: This review aims to assess the effectiveness of mHealth to provide mental health care by analyzing articles published in the last year in peer-reviewed, academic journals using strong methodology (randomized controlled trial). Methods: We queried 4 databases (PubMed, CINAHL [Cumulative Index to Nursing and Allied Health Literature], Web of Science, and ScienceDirect) using a standard Boolean search string. We conducted this systematic literature review in accordance with the Kruse protocol and reported it in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) 2020 checklist (n=33). Results: A total of 4 interventions (mostly mHealth) from 14 countries identified improvements in primary outcomes of depression and anxiety as well as in several secondary outcomes, namely, quality of life, mental well-being, cognitive flexibility, distress, sleep, self-efficacy, anger, decision conflict, decision regret, digestive disturbance, pain, and medication adherence. Conclusions: mHealth interventions can provide education, treatment augmentation, and serve as the primary modality in mental health care. The mHealth modality should be carefully considered when evaluating modes of care. Trial Registration: PROSPERO International Prospective Register of Systematic Reviews CRD42022343489; https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=343489

30 August 2022 in JMIR Preprints
Verified
Preprint
Open access
Clemens Scott KruseClemens Scott Kruse
Clemens Scott Kruse
Jose BetancourtJose Betancourt
Jose Betancourt
MGMatthew Gonzales
Matthew Gonzales
KDKennedy Dickerson
Kennedy Dickerson
MNMiah Neer
Miah Neer
BACKGROUND Mental health is a complex condition, highly related to emotion. The COVID-19 pandemic caused a significant spike in depression (from isolation) and anxiety (event related). mHealth and telemedicine offer solutions to augment patient care, provide education, improve symptoms of depression and assuage fears and anxiety. OBJECTIVE The objective of this review is to assess the effectiveness of mHealth to provide mental healthcare by analyzing articles published in the last year in peer-reviewed, academic journals using strong methodology (RCT). METHODS We queried four databases (PubMed, CINAHL, Web of Science, and ScienceDirect) using a standard Boolean search string. We conducted this systematic literature review in accordance with the Kruse Protocol, and we reported it in accordance with PRISMA 2020 (n=33). RESULTS Four interventions (mostly mHealth) from 14 countries identified improvements in both primary outcomes of depression and anxiety as well as several secondary outcomes: quality of life, mental well-being, cognitive flexibility, distress, sleep, self-efficacy, anger, decision conflict, decision regret, digestive disturbance, pain, and medication adherence. CONCLUSIONS mHealth interventions can provide education, treatment augmentation, and serve as the primary modality in mental healthcare. The mHealth modality should be carefully considered when evaluating modes of care. CLINICALTRIAL